These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13361016)

  • 1. [Pyrazinamide-isoniazid; results of a clinical preliminary examination].
    BRECKE F; WENTZ D
    Tuberkulosearzt; 1956 Aug; 10(8):465-73. PubMed ID: 13361016
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyrazinamide-isoniazid in low dosage in treatment of pulmonary tuberculosis.
    ALLISON ST
    Am Rev Tuberc; 1956 Sep; 74(3):400-9. PubMed ID: 13354923
    [No Abstract]   [Full Text] [Related]  

  • 3. Pyrazinamide-isoniazid in patients with previous isoniazid therapy.
    DONNERBERG RL; ATWELL RJ; BROWNING RH
    Am Rev Tuberc; 1957 May; 75(5):846-8. PubMed ID: 13435461
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of pyrazinamide in the chemotherapy of chronic pulmonary tuberculosis; a clinical evaluation of 39 cases treated with rotation therapy.
    CALIX AA; WHITE K
    J Med Assoc State Ala; 1956 Oct; 26(4):81-6. PubMed ID: 13367704
    [No Abstract]   [Full Text] [Related]  

  • 5. [First clinical observations on the treatment of pulmonary tuberculosis with pyrazinamide].
    DADDI G; CORDA M; GRASSI C; BASILICO F
    G Ital Della Tuberc; 1956; 10(1):3-10. PubMed ID: 13305857
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of pulmonary tuberculosis with high alternating dosage of pyrazinamide and isoniazid].
    REALE M; GARAVENTA A; PAOLI G; COSTA G; MORETTI E
    Gazz Med Ital; 1957 Jun; 116(6):245-54. PubMed ID: 13448341
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pyrazinamide & pyrazinamide with isoniazid in pulmonary tuberculosis; comparison with other chemotherapeuticantibiotic combinations].
    POGGIO G; WRUBL A
    Minerva Med; 1957 Sep; 48(70):2795-804. PubMed ID: 13483284
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical indications and evaluations on the treatment of pulmonary tuberculosis with pyrazinamide. II. Association of pyrazinamide with isoniazid or other antimycobacterial agents and to cortisonic drugs].
    PASTEGA G
    G Ital Tuberc Mal Torace; 1961; 15():280-311. PubMed ID: 14484246
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative efficacy of the concurrent use of pyrazinamide and isoniazid with that of other forms of therapy in the treatment of pulmonary tuberculosis.
    SCHWARTZ JA
    Dis Chest; 1957 Oct; 32(4):455-9. PubMed ID: 13473660
    [No Abstract]   [Full Text] [Related]  

  • 10. [Further observations on pyrazinamide].
    NICK J
    Schweiz Z Tuberc Pneumonol; 1956; 13(6):490-7. PubMed ID: 13408971
    [No Abstract]   [Full Text] [Related]  

  • 11. Retreatment of pulmonary tuberculosis. Experiences with various combinations of pyrazinamide, cycloserine, and kanamycin in patients excreting tubercle bacilli resistant to both streptomycin and isoniazid.
    HAAPANEN J; GILL R; RUSSELL WF; KASS I
    Am Rev Respir Dis; 1960 Dec; 82():843-52. PubMed ID: 13710174
    [No Abstract]   [Full Text] [Related]  

  • 12. Pyrazinamide-isoniazid treated tuberculous patients: a five year follow-up.
    CAMPAGNA M; JACOBS S
    J La State Med Soc; 1959 Nov; 111():411-6. PubMed ID: 13807193
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with pyrazinamide].
    DUGGELI O
    Schweiz Z Tuberc Pneumonol; 1956; 13(6):472-82. PubMed ID: 13408969
    [No Abstract]   [Full Text] [Related]  

  • 14. Retreatment of tuberculous patients: an experience with the combined use of high doses of isoniazid, pyrazinamide and cycloserine.
    SALIBA A; BEATTY OA
    South Med J; 1961 Jan; 54():10-6. PubMed ID: 13745634
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.
    Halsey NA; Coberly JS; Desormeaux J; Losikoff P; Atkinson J; Moulton LH; Contave M; Johnson M; Davis H; Geiter L; Johnson E; Huebner R; Boulos R; Chaisson RE
    Lancet; 1998 Mar; 351(9105):786-92. PubMed ID: 9519950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should isoniazid be used in retreatment of tuberculosis despite acquired isoniazid resistance?
    Moulding TS
    Am Rev Respir Dis; 1981 Mar; 123(3):262-4. PubMed ID: 6784621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
    S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [THE RESULTS OBTAINED WITH THE COMBINATION OF PYRAZINAMIDE AND ISONIAZID IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
    SABAR IR; BAYGIN R
    Tip Fak Mecm; 1963; 26():322-30. PubMed ID: 14126600
    [No Abstract]   [Full Text] [Related]  

  • 19. Pyrazinamide-isoniazid: its apparent influence on the reactivation rate in pulmonary tuberculosis.
    Phillips S
    Am Rev Respir Dis; 1967 Mar; 95(3):503-5. PubMed ID: 6066869
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.